Search results for "FDA news"
Warnings added to prostate cancer drugs
Warnings added to prostate cancer drugs
https://immattersacp.org/weekly/archives/2010/10/26/7.htm
26 Oct 2010
Recalls of generic drugs raise safety concerns
This issue also includes stories on antibiotic stewardship and point-of-care ultrasound, as well as conference coverage from the American Public Health Association and CHEST.
https://immattersacp.org/archives/2020/01/recalls-of-generic-drugs-raise-safety-concerns.htm
1 Jan 2020
Coumadin samples recalled
Coumadin samples recalled
https://immattersacp.org/weekly/archives/2010/07/20/9.htm
20 Jul 2010
FDA panel divided on rosiglitazone
FDA panel divided on rosiglitazone
https://immattersacp.org/weekly/archives/2010/07/20/8.htm
20 Jul 2010
Sibutramine pulled from the market
Sibutramine pulled from the market
https://immattersacp.org/weekly/archives/2010/10/19/8.htm
19 Oct 2010
Leflunomide gets new boxed warning
Leflunomide gets new boxed warning
https://immattersacp.org/weekly/archives/2010/07/20/10.htm
20 Jul 2010
Unapproved prescription cough, cold, allergy meds pulled
ACP Job Placement Center calls for job seekers' profiles
https://immattersacp.org/weekly/archives/2011/03/08/8.htm
8 Mar 2011
Bisphosphonates to carry warning about femur fractures
Bisphosphonates to carry warning about femur fractures
https://immattersacp.org/weekly/archives/2010/10/19/9.htm
19 Oct 2010
Opioid manufacturers told to develop physician, patient education
As part of a new federal effort to reduce prescription drug abuse in the U.S., the FDA will begin requiring a Risk Evaluation and Mitigation Strategy (REMS) for all extended-release and long-acting opioid medications.
https://immattersacp.org/weekly/archives/2011/04/26/6.htm
26 Apr 2011